Click here to BLOCK YOUR CONTENT SPACE IN OUR NEXT ISSUES |
|
|
Latest News & Press Releases |
|
|
|
|
Moderna and Pfizer COVID Vaccines: The Comparison.
There is a thin line between eagerness and desperation, we are aware. The COVID-19 pandemic has made us witness both. With so much taking place in the medical & the health fraternity across..
|
| |
| |
|
IATA addresses vaccine transportation challenges with new guidance.
IATA has published guidance for the air cargo industry to follow when transporting Covid-19 vaccines to ensure that they are moved safely and securely in what it says is the "largest and most...
|
|
|
|
| | |
| |
|
|
|
Pharmaceutical Supply Chains Ready to Manage the 'Biggest Security Challenge for a generation' as the World awaits new Covid Vaccine.
Pharmaceutical supply chains are about to face their biggest security challenge for a generation as the world prepares for life changing deliveries of Covid...
|
|
| | | | |
| |
|
Virgin Atlantic Cargo launches new pharma service as it prepares for vaccine
Virgin Atlantic Cargo has added a new pharma service ahead of the launch of a new Covid-19 vaccine. The airline said its new Pharma Secure..
|
|
|
|
|
| |
|
|
|
New guidelines for independent batch control of COVID-19 vaccines by EU laboratories.
Three new Official Control Authority Batch Release guidelines outlining the tests to be performed by the EU's Official Medicines Control Laboratories...
|
|
|
| |
| |
|
Contract for innovative delivery system for COVID-19 vaccine.
Croda International Plc , announces that it has recently entered into an agreement with Pfizer Inc. to supply novel excipients used in the manufacture of a COVID-19 vaccine candidate.
|
|
|
|
| | |
|
| |
|
|
|
CPhI & P-MEC China 2020 adapts to customer needs with hybrid pharma event.
CPhI & P-MEC China returns as a hybrid event in Shanghai (16-18 December, 2020), with a physical exhibition running alongside Virtual Expo Connect..
|
|
| | | | |
| |
|
Oxford Biomedica and PhoreMost enter gene therapy discovery collaboration.
Oxford Biomedica plc , a leading gene and cell therapy group and PhoreMost Limited, the UK based biopharmaceutical company dedicated to developing drugs against intractable disease targets...
|
|
|
|
|
| |
|
|
|
Llama nanobodies could be a powerful weapon against COVID-19.
The researchers at the University of Pittsburgh School of Medicine describe a new method to extract tiny but extremely powerful SARS CoV 2 antibody fragments from llamas, which could be fashioned...
|
|
|
| |
|
CureVac's COVID-19 Vaccine Candidate, CVnCoV, Suitable for Standard Fridge Temperature Logistics.
CureVac N.V., announced that its mRNA-based COVID-19 vaccine candidate, CVnCoV, remained stable and within defined specifications..
|
|
|
|
|